NCT00686504View on ClinicalTrials.gov

Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Healthy

Interventions

DRUG

AZD2066

single dose of oral dose, 3 times per subject

DRUG

radioligand [11C] AZ12713580

single dose of iv administered 4 times per subject (3 times together with AZD2066)

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY